Skip to main content

Flow Cytometry & Cell Sorting Shared Resource

The mission of the Flow Cytometry & Cell Sorting (FCCS) Shared Resource is to provide the MUSC Hollings Cancer Center research community with an integrated platform to sort and analyze cells and evaluate preclinical and clinical experimental data in a cell-specific manner.

Flow cytometric techniques allow for rapid phenotypic and functional analysis of biological processes and isolation of single cells, methodologies that are critical for detailed analyses of cell types contributing to the complex processes of cancer initiation, metastasis, and progression.

FCCS staff work closely with Hollings members to develop, promote, and deliver high-quality service, data analysis, and experimental design. FCCS services include consultation, training, education, data analyses, and data preparation for publication.

Schedule Use

Staff

Director

Amanda C. LaRue, Ph.D.
Professor, Pathology & Laboratory Medicine
laruerc@musc.edu

Director of Operations

B. Jacob Kendrick, MS, SCYM (ASCP)
kendricb@musc.edu
843-792-9602

Mass Cytometry Specialist

Carsten Krieg, Ph.D.
Assistant Professor, Pathology & Laboratory Medicine
kriegc@musc.edu
843-792-9995

Research Specialist – Flow Cytometry

Kirsten Hughes
mcdanelk@musc.edu
843-792-8115

Kendell Peterson, Ph.D.
petke@musc.edu
843-792-8115

Research Specialist – Mass Cytometry

Ben Caiello
caiello@musc.edu
843-792-8115

Flow cytometry enables rapid analysis of single events or cells as they flow past single or multiple lasers.

Services

User-based (unassisted) Flow Cytometric Analysis

Equipment is available 24/7 for trained investigators. During regular working hours, operators are available to assist with setup, running samples, and troubleshooting.

Assisted Flow Cytometric Analysis

An operator is available for the Fortessa X-20, LSRFortessa, and FACSVerse during regular working hours to provide general assistance as well as standard assays including cell death, proliferation, cell cycle, Ca++ flux, etc.

Imaging Flow Cytometry

The FCCS offers imaging flow cytometry as an assisted-use service on the Luminex ImageStream. The ImageStreamX Mk II System is a benchtop, multispectral, imaging flow cytometer designed for the acquisition of up to 12 channels of cellular imagery, allowing users to locate and quantify the distribution of signals on, within, or between cells.

Cell Sorting

The FCCS offers high-speed cell sorting services for isolation of complex and rare cell populations. The staff of the FCCS has considerable expertise in the design and implementation of novel methodologies for cell/particle isolation and is available to work with investigators to support study goals. Cell sorting is provided as an operator-based assisted service.

Mass Cytometry

The FCCS provides mass cytometry services for high-dimensional single-cell analysis. The Helios (CyTOF) platform is currently capable of simultaneously analyzing 50 parameters. Mass cytometry acquisition is provided as an operator-based assisted service only. Please contact Dr. Krieg for scheduling sample dropoffs. Under Helpful Links below, you will find some entry points for high-dimensional data analysis.

Spectral Flow Cytometry

The FCCS offers investigators access to a Cytek Northern Lights Spectral Analyzer. This 3 laser system has 38 Avalanche PhotoDiode detectors capable of reading the complete spectrum of every fluorochrome in your panel, allowing for combinations of fluorochromes that would be incompatible on other instruments (APC and AF647, e.g.). Spectral analysis represents the future of flow cytometry by bridging the gap between conventional flow and mass cytometry. The Northern Lights is available for both assisted and unassisted use.

Additional Information & Helpful Links

Publication Acknowledgment

If you publish a manuscript including research supported by the Flow Cytometry & Cell Sorting Shared Resource, the following text is to be placed in the acknowledgment section: "Supported in part by the Flow Cytometry and Cell Sorting Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)."

Select References

Jiang, H., Fu, D., Pasupuleti, S. K., Ramdas, B., Long, A., Ramadan, A. M., Yang, J., Kumar, R., Hartman, J. H., Kendrick, B. J., Simpson, E., Gao, H., Liu, Y., Moore, D., Subramanian, S., Berto, S., Gopalakrishnapillai, A., Barwe, S. P., Guo, H., Cheung, N. V., & Paczesny, S. (2025). ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche. Nature Communications, 16(1), 6580.

Elshaer, M., Howley, B. V., & Howe, P. H. (2025). ARIH1 Inhibition promotes microtubule stability and sensitizes breast cancer cells to microtubule-stabilizing agents. Cancers, 17(5), 782.

Valentín-Quiroga, J., Zarauza-Santoveña, A., López-Collazo, E., & Ferreira, L. M. R. (2025). Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipients. Frontiers in Immunology, 16, 1601385.

Fu, D., Jiang, H., Long, A., Harris, E., Guo, H., Capitano, M. L., Wrangle, J., Faust, J. R., Gopalakrishnapillai, A., Pasupuleti, S. K., Ramdas, B., Kapur, R., Barwe, S. P., Cheung, N. V., & Paczesny, S. (2025). Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway. Nature Communications, 16(1), 6369.

Rees, A., Villamor, E., Evans, D., Gooz, M., Fallon, C., Mina-Abouda, M., Disharoon, A., Eblen, S. T., & Delaney, J. R. (2025). Screening methods to discover the FDA-approved cancer drug encorafenib as optimally selective for metallothionein gene loss ovarian cancer. Genes, 16(1), 42.

Golick, L., Robinson, R. M., Reyes, L., St Thomas, N., Klinzing, K., O'Connor, E. C., Ferreira, L. M. R., & Dolloff, N. G. (2025). A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemia. Blood Cancer Journal, 15(1), 198.

Yong, H. H., Borland, R., Le Grande, M., Hu, C. C., Gartner, C., Hyland, A., & Cummings, K. M. (2026). Understanding the role of cessation fatigue in smoking relapse: Findings from the International Tobacco Control Four Country Smoking and Vaping Survey. Addiction (Abingdon, England), 121(2), 340–348.

Fréreux, C., Karam, J. A. Q., Howley, B. V., Granger, B., Chakraborty, P., Vaena, S., Romeo, M., Dalton, A. C., Mohanty, B. K., Mehrotra, S., & Howe, P. H. (2026). PCBP1 binding to single-stranded poly-cytosine motifs enhances cGAS sensing and impairs breast cancer development. Communications Biology, 9(1), 179.

Gudi, R., & Vasu, C. (2026). Centrosomal P4.1-associated protein is a novel regulator of ESCRT pathway function during endosome maturation. iScience, 29(2), 114659.

Hill, M. A., Tennant, M., Watts, B., Atkinson, C., O'Neil, R., Engelhardt, K. E., & Gibney, B. C. (2026). Evaluation of ventilation at 10 °C as the optimal storage condition for donor lungs in a murine model. Scientific Reports, 16(1), 7228.

Savoca, M. T., Takemoto, K., Hu, J., Li, L., Zhong, Z., & Lemasters, J. J. (2026). Zonal hepatocellular responses to acute ethanol consumption: impacts on mitochondrial function and liver metabolism. Toxicological Sciences : An Official Journal of the Society of Toxicology, 209(3), kfag013.

Gerber, R., Griner, J., Guglietta, S., Krieg, C., & Robinson, M. D. (2026). MIMIC: a flexible pipeline to register and summarize IMC-MSI experiments. Communications Biology, 9(1), 712.

Peterson, K., Turos-Cabal, M., Shahani, P., Salvador, A. D., Swiderska-Syn, M., Ferretti, G. D. S., Alfaro-Quinde, C., Kliebe, V., Finelli, L., Howell, A. J., Vieira, M. E., Palomo-Caturla, I., Fei, D. L., Wynn, D. T., Martin, V., Barnoud, T., & Rodriguez-Blanco, J. (2026). CK1α agonists attenuate medulloblastoma stemness and relapse risk. Cell Death & Disease, 17(1), 545.

Griner, J., Gerber, R., Robinson, M. D., Krieg, C., & Guglietta, S. (2026). Resolving sialylated N-glycans and immune cell landscapes using a unified same-section IMC-MSI workflow. BioRxiv : The Preprint Server for Biology, 2026.02.21.707206.

Chattopadhyay, A., O'Connor, E. C., Tingler, A. M., Helke, K. L., Engevik, M. A., & Ferreira, L. M. R. (2026). MUC4-targeted CAR-T cells restrain chemotherapy-resistant colorectal cancer. BioRxiv : The Preprint Server for Biology, 2026.02.26.708339.